4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-26-000125
SVP & Chief Accounting Officer sold 357 shares at $483.36 ($172,560)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ambrose Kristen · SVP & Chief Accounting Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-26 | Sale : show line 1 in the form 10b5-1 | −357 | $483.36 | $172,560 | 6,624 | D |
| Open-market sales · 357 sh · avg $483.36 · $172,560 | ||||||
Loading xslF345X05/wk-form4_1772485797.xml…